Business

In this article NGCA SPCE Richard Branson’s Virgin Orbit, with a rocket under the wing of a modified Boeing 747 jetliner, takes off for a key drop test of its high-altitude launch system for satellites from Mojave, California, July 10, 2019. Mike Blake | Reuters Virgin Orbit, the satellite-launching spinoff of Sir Richard Branson’s Virgin
0 Comments
A young man in West Virginia receives the vaccine while overlooking the West Virginia Capitol Building in Riggleman Hall. Stephen Zenner | LightRocket | Getty Images The number of cases of a heart inflammation condition in 16-to-24-year-olds was higher than expected after they received their second dose of Pfizer or Moderna’s Covid-19 vaccines, the Centers for
0 Comments
A patient suffering from COVID-19 receives treatment at the coronavirus disease (COVID-19) Intensive Care Unit (ICU) of the “Klinikum Darmstadt” clinic in Darmstadt, Germany, May 20, 2021. Kai Pfaffenbach | Reuters LONDON — The cheap and widely-available drug aspirin does not improve survival for patients hospitalized with Covid-19, a U.K. study has found. Oxford University
0 Comments
A person skateboards past Biogen Inc. headquarters in Cambridge, Massachusetts, on Monday, June 7, 2021. Adam Glanzman | Bloomberg | Getty Images Biogen on Tuesday faced tough questions from Wall Street analysts over the $56,000 annual cost of its newly approved Alzheimer’s drug Aduhelm – a price tag executives are calling “fair” and “responsible.” Shares
0 Comments
In this article BIIB Dementia expert Dr. Jason Karlawish told CNBC he’s skeptical of the Food and Drug Administration’s approval of Biogen‘s Alzheimer’s disease drug, Aduhelm, saying “the evidence to approve the drug wasn’t sufficient.” “Another study is needed to establish whether this drug, in fact, is effective. Unfortunately, the FDA approved the drug for
0 Comments
Dr. Scott Gottlieb told CNBC on Monday that fully vaccinated Americans should feel well-protected against the coronavirus throughout the summer. However, Gottlieb, who serves on the board of vaccine maker Pfizer, said an additional dose might to boost immunity could still be needed later this year. “I think you could feel safe through the summer,” the former
0 Comments